✦ LIBER ✦

Calculation of received dose intensity for combinations of drugs using small-cell lung carcinoma treatment regimens as examples

✍ Scribed by Galen L. Wampler; John G. Fryer

Book ID: 104887178
Publisher: Springer
Year: 1992
Tongue: English
Weight: 872 KB
Volume: 30
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00686312

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Calculation of received dose intensity f

Calculation of received dose intensity for combinations of drugs using small-cell lung carcinoma treatment regimens as examples

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 127 KB

203 Intensive CODE regimen for the treat

203 Intensive CODE regimen for the treatment of limited and extensive stage small cell lung carcinoma

✍ Franciosi, V.; Vasini, G.; Leonardi, F.; Ceci, G.; Mambrini, A.; Quarta, M.C.; C 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Single dose thoracic irradiation after a

Single dose thoracic irradiation after a short intensive chemotherapy regimen for the treatment of small cell lung cancer (SCLC)

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Combination chemotherapy using high or l

Combination chemotherapy using high or low dose methotrexate for small cell carcinoma of the lung — A randomised trial

✍ Andrew M. Arnold; Christopher J. Williams; Graham M. Mead; Roger B. Buchanan; Jo 📂 Article 📅 1984 🏛 Springer US 🌐 English ⚖ 434 KB

Teniposide (VM-26) as a single drug trea

Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma : A Phase II study of the Southwest Oncology Group

✍ Petre N. Grozea; John J. Crowley; Vikki A. Canfield; Laura Kingsbury; S. William 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 3 views

## Background: Teniposide (vm-26) was reported to have activity in small cell lung carcinoma (sclc). the authors performed a phase ii study of teniposide as a treatment for patients with previously untreated extensive sclc. ## Methods: The study was open to patients with a histologic or cytologic

Teniposide (VM-26) as a single drug trea

Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: A phase II study of the southwest oncology group

✍ Jacob J. Lokich 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 3 views